Please login to the form below

Not currently logged in
Email:
Password:

relebactam

This page shows the latest relebactam news and features for those working in and with pharma, biotech and healthcare.

MSD launches antibiotic combo Recarbrio in UK

MSD launches antibiotic combo Recarbrio in UK

Earlier this year, the European Commission approved Recarbrio (imipenem/cilastatin/relebactam) for the treatment of infections caused by aerobic Gram-negative organisms in adults with limited treatment options. ... The regimen combines MSD’s

Latest news

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...